192 related articles for article (PubMed ID: 8944665)
21. Parenteral nutrients in rat suppresses hepatic vagal afferent signals from portal vein to hypothalamus.
Niijima A; Meguid MM
Surgery; 1994 Aug; 116(2):294-301. PubMed ID: 8047997
[TBL] [Abstract][Full Text] [Related]
22. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
Crespel A; De Boisvilliers F; Gros L; Kervran A
Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
[TBL] [Abstract][Full Text] [Related]
23. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
Rouillé Y; Kantengwa S; Irminger JC; Halban PA
J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
[TBL] [Abstract][Full Text] [Related]
24. Glucose-sensitive afferent nerve fibers in the liver and their role in food intake and blood glucose regulation.
Niijima A
J Auton Nerv Syst; 1983 Oct; 9(1):207-20. PubMed ID: 6663009
[TBL] [Abstract][Full Text] [Related]
25. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
Bojanowska E; Stempniak B
Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
[TBL] [Abstract][Full Text] [Related]
26. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons.
Kakei M; Yada T; Nakagawa A; Nakabayashi H
Auton Neurosci; 2002 Nov; 102(1-2):39-44. PubMed ID: 12492134
[TBL] [Abstract][Full Text] [Related]
28. Intraportal infusion of 2,5-anhydro-D-mannitol increases afferent activity in the common hepatic vagus branch.
Lutz TA; Niijima A; Scharrer E
J Auton Nerv Syst; 1996 Nov; 61(2):204-8. PubMed ID: 8946344
[TBL] [Abstract][Full Text] [Related]
29. The hepatic vagus nerve and the neural regulation of insulin secretion.
Lee KC; Miller RE
Endocrinology; 1985 Jul; 117(1):307-14. PubMed ID: 3891316
[TBL] [Abstract][Full Text] [Related]
30. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands.
Uttenthal LO; Blázquez E
FEBS Lett; 1990 Mar; 262(1):139-41. PubMed ID: 2156728
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.
Ionut V; Hucking K; Liberty IF; Bergman RN
Diabetologia; 2005 May; 48(5):967-75. PubMed ID: 15830188
[TBL] [Abstract][Full Text] [Related]
32. Responses of hepatic and celiac vagal afferents to intraportal mercaptoacetate in rats fed a high-fat or low-fat diet.
Randich A; Spraggins DS; Meller ST; Kelm GR; Cox JE
Neuroreport; 2002 Apr; 13(5):675-9. PubMed ID: 11973469
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
Bojanowska E; Stempniak B
Neuroendocrinology; 2003 Feb; 77(2):119-24. PubMed ID: 12624533
[TBL] [Abstract][Full Text] [Related]
34. Peripheral bombesin decreases gastric vagal efferent activity in part through vagal pathways in rats.
Yoshida-Yoneda E; Taché Y; Kosoyan HP; Wei JY
Am J Physiol; 1994 Jun; 266(6 Pt 2):R1868-75. PubMed ID: 8024041
[TBL] [Abstract][Full Text] [Related]
35. N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo.
O'Harte FP; Mooney MH; Lawlor A; Flatt PR
Biochim Biophys Acta; 2000 Mar; 1474(1):13-22. PubMed ID: 10699485
[TBL] [Abstract][Full Text] [Related]
36. An electrophysiological study on amino acid sensors in the hepato-portal system in the rat.
Niijima A; Meguid MM
Obes Res; 1995 Dec; 3 Suppl 5():741S-745S. PubMed ID: 8653557
[TBL] [Abstract][Full Text] [Related]
37. The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.
Takhar S; Gyomorey S; Su RC; Mathi SK; Li X; Wheeler MB
Endocrinology; 1996 May; 137(5):2175-8. PubMed ID: 8612565
[TBL] [Abstract][Full Text] [Related]
38. Glucagon acts through its own receptors in the presence of functional glucagon-like peptide-1 receptors on hamster insulinoma.
Marie JC; Boissard C; Skoglund G; Rosselin G; Breant B
Endocrinology; 1996 Oct; 137(10):4108-14. PubMed ID: 8828464
[TBL] [Abstract][Full Text] [Related]
39. Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
Bojanowska E; Stempniak B
J Endocrinol; 2002 Feb; 172(2):303-10. PubMed ID: 11834448
[TBL] [Abstract][Full Text] [Related]
40. Effect of hepatic portal injection of ouabain on the hepato-sympathoadrenal reflex.
Bergeron R; Lavoie JM; Cardin S; Latour MG; Désy F; Hélie R; Yamaguchi N
Physiol Behav; 1998 Mar; 63(5):779-85. PubMed ID: 9617999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
